Lifestyle Intervention for Patients With Multiple Sclerosis
NCT ID: NCT05402501
Last Updated: 2022-06-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
900 participants
OBSERVATIONAL
2021-04-15
2024-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pilot and Feasibility Trial of a Telehealth Dietary Intervention for MS
NCT03372187
Multiple Sclerosis Self Monitoring Study
NCT06125301
Sport, Rehabilitation and Nutrition in Multiple Sclerosis: The LINUS Project
NCT04881422
Activity and Balanced Eating to Reduce Comorbidities and Symptoms of MS
NCT03808545
Functional Outcomes From Diets in Multiple Sclerosis
NCT05327322
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with multiple sclerosis (MS)
Patients will participate in an online lifestyle program organized by Voeding Leeft, which consists of four main topics: diet, physical activity, relaxation and sleep.
Lifestyle intervention program "Leef! met MS"
The lifestyle program consists of a three-months intensive program, followed by a 21-months 'inspiration' program with occasional meetings.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lifestyle intervention program "Leef! met MS"
The lifestyle program consists of a three-months intensive program, followed by a 21-months 'inspiration' program with occasional meetings.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Motivated to adapt their lifestyle
* Able to complete online questionnaires by themselves
* Able to do grocery shopping and to (let someone) prepare the meals from the program
* In a subpopulation (n=200): daily use of a smartphone
Exclusion Criteria
* An inability to speak or read Dutch
* Vegan diet
* Not willing to eat fish
* BMI \<18.5 and \>35 kg/m2
* Pregnant or breastfeeding
* Diagnosis of an eating disorder or psychiatric disorder (according to the DSM-V criteria)
* History of bariatric surgery
* Another disorder, such as inflammatory bowel disease (e.g. Crohn's disease or ulcerative colitis), cardiovascular disease (e.g. severe heart failure), malignancy, diabetes type 1 and 2
* Having previously participated in a lifestyle intervention of Voeding Leeft or currently participating in another lifestyle program or lifestyle study.
* Currently under treatment at a dietician or lifestyle coach
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National MS Foundation, The Netherlands
UNKNOWN
Voeding Leeft
UNKNOWN
Amsterdam UMC, location VUmc
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ilse Nauta
Coordinating investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Brigit de Jong
Role: PRINCIPAL_INVESTIGATOR
Amsterdam UMC, location VUmc
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Amsterdam UMC, location VUmc
Amsterdam, North Holland, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021.0089
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.